Cambridge Isotope Lab产品代理

Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer   of stable isotopes and stable isotope-labeled compounds. With over 600   employees and laboratories in five countries, CIL specializes in the process   of labeling biochemical and organic compounds with highly enriched, stable   (nonradioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. Our   chemists substitute common atoms (e.g., 1H, 12C, 14N, 16O) with rare, highly   valued isotopes (e.g., 2H or D, 13C, 15N, 18O) so that the final product can   be readily measured or traced using mass spectrometry (MS) or nuclear   magnetic resonance (NMR). CIL’s products are utilized in laboratories, medical, government and   academic research centers and health care facilities worldwide.

We are proud that CIL products have contributed to medical advancements in cancer research, drug development, environmental analysis, and medical diagnostic research. In the

past decade, as the fields of proteomics and metabolomics have   developed as leading techniques for determining biomarkers for disease   presence, progression and the monitoring of therapeutic response, CIL has   worked closely with industry leaders and researchers to provide the stable   isotope-labeled tools needed for improved quantitation and qualification of   complex biological systems.

In the past few decades, stable isotopes have found their place in   an ever-expanding commercial scale applications in pharmaceuticals,   semiconductors, flat panel displays as well as other high technology fields,   specifically with deuterium oxide (D2O) and deuterium gas. Pharmaceutical   companies have begun to investigate the deuteration of molecules that provide   advantages over their existing nondeuterated counterparts. In addition, increasing   research into the potential medical advantages of new deuterated drugs is   also occurring. In high technology, deuterated organic molecules and   deuterium gas are commonly used in the manufacturing of microelectronics and   OLEDs, which contribute to the increased lifetime of the devices.

CIL's vision began when it was founded in 1981 by Dr. Joel Bradley, an organic chemist from MIT. Drawing on a commitment to high-quality products, superior customer service, innovative new products and breadth of product lines, CIL quickly emerged as a leader in its field. CIL now produces